Resonance Generating Electromagnetic Fields for GBM Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for aggressive brain tumors like Glioblastoma Multiforme (GBM) are limited in effectiveness, with median survival time less than a year and less than 5% of patients surviving five years, due to resistance to standard chemotherapies and the need for invasive methods.
Innovation Solution
The use of non-invasive modulated electromagnetic radiation that targets specific resonant frequencies of biological substances critical to the disease, generating a modulated broadband signal and a booster signal to create a tuned electromagnetic field that affects biological activities, potentially inducing cell death or slowing disease progression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard chemotherapy (temozolomide) is used to treat GBM, then some tumor cells are killed, but tumor resistance develops and treatment effectiveness decreases
Solution Approach 1:
The patent replaces chemical therapy (temozolomide) with a physical field-based approach using electromagnetic radiation at specific resonant frequencies. This substitution targets the MGMT enzyme's resonant frequency to disrupt its function, thereby overcoming chemical resistance without requiring the tumor to adapt to new chemical agents.
Solution Approach 2:
The invention changes the treatment parameter from chemical concentration to electromagnetic frequency. By identifying and applying the specific resonant frequency of the MGMT enzyme (approximately 2.45 GHz), the treatment effectively disables the resistance mechanism rather than competing with it, eliminating the adaptability advantage tumors have against chemotherapy.
2Productivity
If invasive surgical resection and aggressive chemotherapy regimens are used, then tumor burden is reduced, but patient morbidity and quality of life deteriorate
Solution Approach 1:
The patent replaces invasive mechanical surgery and aggressive chemotherapy with non-invasive electromagnetic field application. The electromagnetic radiation penetrates the skull and directly targets MGMT in the tumor tissue, achieving tumor cell killing without surgical incisions, anesthesia, or systemic chemotherapy side effects.
Solution Approach 2:
The electromagnetic field acts as an intermediary that delivers therapeutic effect remotely through the skull. This eliminates the need for direct physical contact with surgical instruments or injection of toxic chemicals, thereby reducing morbidity while maintaining treatment efficacy.
3Adaptability or versatility
If trial-and-error methods are used to determine resonant frequencies, then treatment can be customized, but treatment time and complexity increase
Solution Approach 1:
The patent performs preliminary determination of resonant frequencies during the development and validation phase. Once the characteristic resonant frequency of MGMT (approximately 2.45 GHz) is established, it can be directly applied in clinical settings without requiring trial-and-error adjustments for each patient, thus maintaining customization while eliminating time loss.
Solution Approach 2:
The invention uses spectral analysis to create a frequency profile or 'fingerprint' of the target molecule (MGMT). This spectral signature serves as a template that can be replicated and applied across different patients and treatments, eliminating the need to rediscover the resonant frequency for each case while maintaining precise targeting.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for a non-invasive treatment that can induce apoptosis in cancer cells or slow disease progression without the need for cumbersome calculations or trial-and-error, demonstrating potential in reducing GBM cell growth by 30% and achieving significant reductions in other disease conditions like Mycobacterium Tuberculosis and Human Immunodeficiency Virus.
Implementation Method 1
amplified resonance within that target that helps stop a disease
Data Source
AI summary
The present disclosure relates, according to some embodiments, to an electromagnetic resonance-based disease treatment system that comprises a processing unit configured to generate a resonant frequency signal and a radiating antenna configured to radiate an electromagnetic field based on the resonant frequency signal. The resonant frequency signal may carry at least one frequency at which reference materials related to a disease condition resonate. An antenna configuration may be used to determine one or more resonant frequencies of the reference materials. A subject having or at risk of having the disease condition may be exposed to the electromagnetic field in order to treat the disease condition.